Relmada Therapeutics, Inc. (RLMD)
4.11
-0.09
(-2.14%)
USD |
NASDAQ |
Feb 10, 13:28
Relmada Therapeutics Market Cap : 301.40M for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.417B |
| Invivyd, Inc. | 367.17M |
| Arcellx, Inc. | 3.848B |
| ACADIA Pharmaceuticals, Inc. | 3.855B |
| Alnylam Pharmaceuticals, Inc. | 42.20B |
Market Cap Related Metrics
| Price to Book Value | 31.84 |
| Price | 4.11 |
| Earnings Yield | -43.72% |